Skip to content

The Impact of Real Time Ventilation Feedback on Ventilation Rate and Tidal Volume During Cardiac Arrest.

The Impact of Real Time Ventilation Feedback on Ventilation Rate and Tidal Volume During Cardiac Arrest.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06528704
Enrollment
100
Registered
2024-07-30
Start date
2024-05-20
Completion date
2026-12-31
Last updated
2025-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest

Brief summary

During out-of-hospital cardiopulmonary resuscitation, patient are first ventilated without ventilation feedback (but with a flowsensor connected), hereafter patients are ventilated with the use of ventilation feedback.

Detailed description

During cardiac arrest, patients are intubated, ventilation is performed using a manual resuscitator. Hereafeter, a flowsensor is connected. During the first cycle, patients are ventilated without any feedback (whilst the sensor is recording the delivered ventilation). During the second cycle, realtime delivered flow is shown on the screen, informing the user on the delivered ventilation volume and ventilation rate. Data is saved automatically after use.

Interventions

DEVICEVentilation feedback device

Device showing delivered ventilation frequency and volume.

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\-

Exclusion criteria

Traumatic cardiac arrest Inability to intubate patient

Design outcomes

Primary

MeasureTime frameDescription
Delivered ventilation volume2 minutesMeasured ventilation volume (with or without ventilation feedback)
Delivered ventilation frequency2 minutesMeasured ventilation frequency (with or without ventilation feedback)

Countries

Belgium

Contacts

Primary ContactMaxim Vanwulpen, MD
maxim.vanwulpen@uzgent.be09 332 21 11
Backup ContactSaid Hachimi-Idrissi, MD
09 332 21 11

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026